In the presence of IL-21 human cord blood T cells differentiate to IL-10-producing Th1 but not Th17 or Th2 cells

International Immunology

Volumn 25, Issue 3, 2013, Pages 157-169

  Doganci, Aysefa ^a   Birkholz, Julia ^a   Gehring, Stephan ^a   Puhl, Alexander G ^a   Zepp, Fred ^a   Meyer, Claudius U ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Adult blood; IFN ; IL 10; Neonatal immunology; Umbilical cord blood

Indexed keywords

CD28 ANTIGEN; CD3 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 21; STAT1 PROTEIN; STAT3 PROTEIN; TRANSCRIPTION FACTOR GATA 3;

ADAPTIVE IMMUNITY; ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DNA SYNTHESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LYMPHOCYTE DIFFERENTIATION; NEWBORN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; STIMULATION; TH1 CELL; TH17 CELL; TH2 CELL; UMBILICAL CORD BLOOD;

ADULT; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELLS, CULTURED; FETAL BLOOD; GENE EXPRESSION PROFILING; HUMANS; INFANT, NEWBORN; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKINS; T-LYMPHOCYTE SUBSETS; TH1 CELLS; TH1-TH2 BALANCE; TH17 CELLS; TH2 CELLS;

EID: 84876494137     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxs097     Document Type: Article

References (51)

1. Wilson, C. B. 1991. The ontogeny of T lymphocyte maturation and function. J. Pediatr. 118:S4.
2. Harris, D. T., Schumacher, M. J., Locascio, J. et al. 1992. Phenotypic and functional immaturity of human umbilical cord blood T lymphocytes. Proc. Natl. Acad. Sci. U S A 89:10006.
3. Levy, O. 2007. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat. Rev. Immunol. 7:379.
4. Black, R. E., Cousens, S., Johnson, H. L. et al. 2010. Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet 375:1969.
5. Delespesse, G., Yang, L. P., Ohshima, Y. et al. 1998. Maturation of human neonatal CD4+ and CD8+ T lymphocytes into Th1/Th2 effectors. Vaccine 16:1415.
6. Goriely, S., Vincart, B., Stordeur, P. et al. 2001. Deficient IL-12(p35) gene expression by dendritic cells derived from neonatal monocytes. J. Immunol. 166:2141.
7. Krumbiegel, D., Zepp, F. and Meyer, C. U. 2007. Combined toll-like receptor agonists synergistically increase production of inflammatory cytokines in human neonatal dendritic cells. Hum. Immunol. 68:813.
8. Lewis, D. B., Larsen, A. and Wilson, C. B. 1986. Reduced interferon-gamma mRNA levels in human neonates. Evidence for an intrinsic T cell deficiency independent of other genes involved in T cell activation. J. Exp. Med. 163:1018.
9. Marodi, L. 2002. Down-regulation of Th1 responses in human neonates. Clin. Exp. Immunol. 128:1.
10. De Wit, D., Olislagers, V., Goriely, S. et al. 2004. Blood plasmacytoid dendritic cell responses to CpG oligodeoxynucleotides are impaired in human newborns. Blood 103:1030.
11. Wilson, C. B., Westall, J., Johnston, L., Lewis, D. B., Dower, S. K. and Alpert, A. R. 1986. Decreased production of interferongamma by human neonatal cells. Intrinsic and regulatory deficiencies. J. Clin. Invest. 77:860.
12. Schultz, C., Strunk, T., Temming, P., Matzke, N. and Hartel, C. 2007. Reduced IL-10 production and -receptor expression in neonatal T lymphocytes. Acta Paediatr. 96:1122.
13. Kassner, N., Krueger, M., Yagita, H. et al. 2010. Cutting edge: plasmacytoid dendritic cells induce IL-10 production in T cells via the delta-like-4/notch axis. J. Immunol. 184:550.
14. Vosshenrich, C. A. and Di Santo, J. P. 2001. Cytokines: IL-21 joins the gamma(c)-dependent network? Curr. Biol. 11:R175.
15. Leonard, W. J. and Spolski, R. 2005. Interleukin-21: a modulator of lymphoid proliferation, apoptosis and differentiation. Nat. Rev. Immunol. 5:688.
16. Parrish-Novak, J., Dillon, S. R., Nelson, A. et al. 2000. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 408:57.
17. Wurster, A. L., Rodgers, V. L., Satoskar, A. R. et al. 2002. Interleukin 21 is a T helper (Th) cell 2 cytokine that specifically inhibits the differentiation of naive Th cells into interferon gamma-producing Th1 cells. J. Exp. Med. 196:969.
18. Zhou, L., Ivanov, II, Spolski, R. et al. 2007. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat. Immunol. 8:967.
19. Korn, T., Bettelli, E., Gao, W. et al. 2007. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 448:484.
20. Nurieva, R., Yang, X. O., Martinez, G. et al. 2007. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 448:480.
21. Pesce, J., Kaviratne, M., Ramalingam, T. R. et al. 2006. The IL-21 receptor augments Th2 effector function and alternative macrophage activation. J. Clin. Invest. 116:2044.
22. Chtanova, T., Tangye, S. G., Newton, R. et al. 2004. T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1/Th2 effector cells that provide help for B cells. J. Immunol. 173:68.
23. Pot, C., Jin, H., Awasthi, A. et al. 2009. Cutting edge: IL-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cells. J. Immunol. 183:797.
24. Bauquet, A. T., Jin, H., Paterson, A. M. et al. 2009. The costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the development of follicular T helper cells and TH-17 cells. Nat. Immunol. 10:167.
25. Baker, S. J., Rane, S. G. and Reddy, E. P. 2007. Hematopoietic cytokine receptor signaling. Oncogene 26:6724.
26. Publicover, J., Goodsell, A., Nishimura, S. et al. 2011. IL-21 is pivotal in determining age-dependent effectiveness of immune responses in a mouse model of human hepatitis B. J. Clin. Invest. 121:1154.
27. Cope, A., Le Friec, G., Cardone, J. and Kemper, C. 2011. The Th1 life cycle: molecular control of IFN-gamma to IL-10 switching. Trends Immunol. 32:278.
28. Wong, M. T., Ye, J. J., Alonso, M. N. et al. 2010. Regulation of human Th9 differentiation by type I interferons and IL-21. Immunol. Cell Biol. 88:624.
29. Putheti, P., Awasthi, A., Popoola, J., Gao, W. and Strom, T. B. 2010. Human CD4 memory T cells can become CD4+IL-9+ T cells. PLoS One 5:e8706.
30. Sakaguchi, S., Yamaguchi, T., Nomura, T. and Ono, M. 2008. Regulatory T cells and immune tolerance. Cell 133:775.
31. Cardone, J., Le Friec, G., Vantourout, P. et al. 2010. Complement regulator CD46 temporally regulates cytokine production by conventional and unconventional T cells. Nat. Immunol. 11:862.
32. Jankovic, D., Kullberg, M. C., Feng, C. G. et al. 2007. Conventional T-bet+Foxp3- Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection. J. Exp. Med. 204:273.
33. Anderson, C. F., Oukka, M., Kuchroo, V. J. and Sacks, D. 2007. CD4+CD25-Foxp3- Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis. J. Exp. Med. 204:285.
34. Roncarolo, M. G., Gregori, S., Battaglia, M., Bacchetta, R., Fleischhauer, K. and Levings, M. K. 2006. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol. Rev. 212:28.
35. Fujio, K., Okamura, T. and Yamamoto, K. 2010. The family of IL-10-secreting CD4+ T cells. Adv. Immunol. 105:99.
36. Wegmann, T. G., Lin, H., Guilbert, L. and Mosmann, T. R. 1993. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol. Today 14:353.
37. Guilbert, L. J. 1996. There is a bias against type 1 (inflammatory) cytokine expression and function in pregnancy. J. Reprod. Immunol. 32:105.
38. Herberth, G., Hinz, D., Roder, S. et al. 2011. Maternal immune status in pregnancy is related to offspring's immune responses and atopy risk. Allergy 66:1065.
39. Pot, C., Apetoh, L., Awasthi, A. and Kuchroo, V. K. 2010. Molecular pathways in the induction of interleukin-27-driven regulatory type 1 cells. J. Interferon Res. 30:381.
40. Spolski, R. and Leonard, W. J. 2008. Interleukin-21: basic biology and implications for cancer and autoimmunity. Annu. Rev. Immunol. 26:57.
41. Sonderegger, I., Kisielow, J., Meier, R., King, C. and Kopf, M. 2008. IL-21 and IL-21R are not required for development of Th17 cells and autoimmunity in vivo. Eur. J. Immunol. 38:1833.
42. Coquet, J. M., Chakravarti, S., Smyth, M. J. and Godfrey, D. I. 2008. Cutting edge: IL-21 is not essential for Th17 differentiation or experimental autoimmune encephalomyelitis. J. Immunol. 180:7097.
43. Herber, D., Brown, T. P., Liang, S., Young, D. A., Collins, M. and Dunussi-Joannopoulos, K. 2007. IL-21 has a pathogenic role in a lupus-prone mouse model and its blockade with IL-21R.Fc reduces disease progression. J. Immunol. 178:3822.
44. Bubier, J. A., Bennett, S. M., Sproule, T. J. et al. 2007. Treatment of BXSB-Yaa mice with IL-21R-Fc fusion protein minimally attenuates systemic lupus erythematosus. Ann. N Y Acad. Sci. 1110:590.
45. Spolski, R., Kashyap, M., Robinson, C., Yu, Z. and Leonard, W. J. 2008. IL-21 signaling is critical for the development of type I diabetes in the NOD mouse. Proc. Natl. Acad. Sci. U S A 105:14028.
46. Kasaian, M. T., Whitters, M. J., Carter, L. L. et al. 2002. IL-21 limits NK cell responses and promotes antigen-specific T cell activation: a mediator of the transition from innate to adaptive immunity. Immunity 16:559.
47. Ouyang, W., Filvaroff, E., Hu, Y. and Grogan, J. 2009. Novel therapeutic targets along the Th17 pathway. Eur. J. Immunol. 39:670.
48. Moroz, A., Eppolito, C., Li, Q., Tao, J., Clegg, C. H. and Shrikant, P. A. 2004. IL-21 enhances and sustains CD8+ T cell responses to achieve durable tumor immunity: comparative evaluation of IL-2, IL-15, and IL-21. J. Immunol. 173:900.
49. Parrish-Novak, J., Foster, D. C., Holly, R. D. and Clegg, C. H. 2002. Interleukin-21 and the IL-21 receptor: novel effectors of NK and T cell responses. J. Leukoc. Biol. 72:856.
50. Hashmi, M. H. and Van Veldhuizen, P. J. 2010. Interleukin-21: updated review of phase I and II clinical trials in metastatic renal cell carcinoma, metastatic melanoma and relapsed/refractory indolent non-Hodgkin's lymphoma. Expert Opin. Biol. Ther. 10:807.
51. Wang, L., Toda, M., Saito, K. et al. 2008. Post-immune UV irradiation induces Tr1-like regulatory T cells that suppress humoral immune responses. Int. Immunol. 20:57.